virtual currency exchange platforms- Top Featured

In addition, it is planned to distribute a cash dividend of 12.3 yuan to all shareholders for every 10 shares, with a total dividend of 4.5 billion yuan. In April this year, Ningde has paid dividends of 22 billion yuan, and this time it totaled 27.4 billion yuan. According to the current market value of 11,900, the corresponding dividend yield is 2.3%! It's really not low.In short, it is the recent big bull stocks that have been announced to reduce their holdings. For example, Yiming Food has 11 consecutive boards, and the price of the world has reached a record high. Zhongyan shares have two 20cm daily limit! They are all popular topics such as AI applications and robots. Many have indeed risen a lot, even to record highs, but the reason is to rub a hot spot. In this case, it is normal for shareholders to reduce their holdings! The human heart is like this, and you can't stop it.Easy to change the world: shareholders intend to reduce their holdings by no more than 3.05% in total;

Let's talk about some encouraging and unintelligent observations. Now the main purpose of everyone's smashing is to adjust positions, not to sell them back. This is the biggest difference from the past few years! Explain that regardless of retail investors, institutions and foreign investors, they still believe in the A-share bull market.Yiming Food issued a suggestive announcement on the risk of stock trading. Since November 26, 2024, the company's stock has been trading daily for 11 consecutive times, with a cumulative turnover rate of 66.9%, which is a risk of a sharp decline in the short term. At the same time, several major shareholders reduced their holdings of shares not exceeding 1% of the total share capital. As of the close of December 10, 2024, the three partnership platforms reduced their holdings by 138,200 shares today.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.

Haineng Industry: The controlling shareholder intends to reduce the company's shares by no more than 3%;Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;